131 related articles for article (PubMed ID: 36775791)
21. Thirty synchronous medullary and papillary thyroid carcinomas.
Zhang D; Yang M; Zhang X; Wang C; Li K; Wang H; Chi H; Sui C; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1153248. PubMed ID: 37065753
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
Erickson LA; Jin L; Nakamura N; Bridges AG; Markovic SN; Lloyd RV
Cancer; 2007 May; 109(10):1965-71. PubMed ID: 17387744
[TBL] [Abstract][Full Text] [Related]
23. Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.
Thomas A; Mittal N; Rane SU; Bal M; Patil A; Ankathi SK; Vaish R
Head Neck Pathol; 2021 Dec; 15(4):1137-1146. PubMed ID: 33840044
[TBL] [Abstract][Full Text] [Related]
24. Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?
Cipriani NA; Nagar S; Kaplan SP; White MG; Antic T; Sadow PM; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH
Thyroid; 2015 Nov; 25(11):1209-16. PubMed ID: 26440366
[TBL] [Abstract][Full Text] [Related]
25. Spinal metastases due to thyroid carcinoma: an analysis of 202 patients.
Kushchayeva YS; Kushchayev SV; Carroll NM; Felger EA; Links TP; Teytelboym OM; Bonichon F; Preul MC; Sonntag VK; Van Nostrand D; Burman KD; Boyle LM
Thyroid; 2014 Oct; 24(10):1488-500. PubMed ID: 24921429
[TBL] [Abstract][Full Text] [Related]
26. NONOPERATIVE MANAGEMENT OF DIFFERENTIATED THYROID CANCER IN CALIFORNIA: A POPULATION-LEVEL ANALYSIS OF 29,978 PATIENTS.
Kuo EJ; Wu JX; Li N; Zanocco KA; Yeh MW; Livhits MJ
Endocr Pract; 2017 Oct; 23(10):1262-1269. PubMed ID: 28816539
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
28. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
29. Co-existence of Papillary and Medullary Thyroid Carcinoma: Reports of Three Cases.
Calapkulu M; Gul OO; Cander S; Sagiroglu MF; Saraydaroglu O; Erturk E; Ersoy C
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S156-S158. PubMed ID: 36210680
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer.
Wolff L; Steindl A; Popov P; Dieckmann K; Gatterbauer B; Widhalm G; Berghoff AS; Preusser M; Raderer M; Kiesewetter B
Clin Exp Metastasis; 2023 Jun; 40(3):217-226. PubMed ID: 37219741
[TBL] [Abstract][Full Text] [Related]
32. Follicular variant papillary thyroid carcinoma in a pediatric population.
Lerner J; Goldfarb M
Pediatr Blood Cancer; 2015 Nov; 62(11):1942-6. PubMed ID: 26131690
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
[TBL] [Abstract][Full Text] [Related]
34. A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.
Englum BR; Pura J; Reed SD; Roman SA; Sosa JA; Scheri RP
World J Surg; 2015 Dec; 39(12):2928-34. PubMed ID: 26324158
[TBL] [Abstract][Full Text] [Related]
35. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
[No Abstract] [Full Text] [Related]
36. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
37. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
Fan YL; Li XQ
Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
[TBL] [Abstract][Full Text] [Related]
38. Mixed medullary-follicular and medullary-papillary carcinoma of the thyroid: one or two entities?
Michal M; Curík R; Macák J; Ludvíková M; Dĕdic K
Zentralbl Pathol; 1993 Nov; 139(4-5):333-5. PubMed ID: 8130165
[TBL] [Abstract][Full Text] [Related]
39. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H
Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476
[TBL] [Abstract][Full Text] [Related]
40. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]